Imugene Limited
Biotechnology ResearchView the employees at
Imugene Limited-
Kirsten Bailey Manufacturing Lead at Imugene Limited
-
Raleigh, North Carolina, United States
-
Rising Star
Kevin Jones HVAC, ELECTRICAL and FACILITY MAINTENANCE PROFESSIONAL-
Durham, North Carolina, United States
-
Rising Star
Jennifer Reinsel Quality Assurance Professional-
Franklinton
-
Rising Star
Josie Tueller Research Associate III at Imugene-
Durham, North Carolina, United States
-
Top 10%
Scott Burian Sr.Director, CMC Regulatory Affairs at Imugene-
Durham, North Carolina, United States
-
Top 5%
Overview
Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies. Our product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies. We are supported by a leading team of international cancer experts with extensive experience in developing new cancer therapies with many approved for sale and marketing for global markets. ASX: IMU
-